Glimilife M 3mg/500mg Tablet SR
Manufacturer
Lakshya Pharma Pvt Ltd
Salt Composition
Glimepiride (3mg) + Metformin (500mg)
Key Information
Short Description
Glimilife M 3mg/500mg Tablet SR is a combination of two medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Dosage Form
Tablet SR
Introduction
Glimilife M 3mg/500mg Tablet SR belongs to a category of medicines known as anti-diabetic drugs. It is a combination of two medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Directions for Use
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glimilife M 3mg/500mg Tablet SR is to be taken with food.
Safety Information
Side Effects
It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal.
Alcohol Warning
It is unsafe to consume alcohol with Glimilife M 3mg/500mg Tablet SR.
Breastfeeding Warning
Glimilife M 3mg/500mg Tablet SR is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Pregnancy Warning
Glimilife M 3mg/500mg Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
How it works
Glimilife M 3mg/500mg Tablet SR is a combination of two antidiabetic medicines: Glimepiride and Metformin. Glimepiride is a sulfonylurea which works by increasing the amount of insulin released by the pancreas in order to lower the blood glucose. Metformin is a biguanide which works by lowering glucose production in the liver, delaying glucose absorption from intestines and increasing the body's sensitivity to insulin.
Quick Tips
Monitor your blood sugar level regularly while you are taking this medicine. Inform your doctor about your diabetes treatment if you are due to have surgery under a general anesthetic. Tell your doctor immediately if you experience any deep or rapid breathing or if you have persistent nausea, vomiting and stomach pain as Glimilife M 3mg/500mg Tablet SR may cause a rare but serious condition called lactic acidosis which is an excess of lactic acid in the blood.
Related Medicines
Glimith MF 3mg/500mg Tablet SR
Sulfamet M 3mg/500mg Tablet SR
Genericart Glimepiride+Metformin 3mg/500mg Tablet SR
Hexaglim-M 3 Tablet SR
Glimric-M3 Tablet SR
Mexfib G 3mg/500mg Tablet SR
Glimper M 3mg/500mg Tablet SR
Mgcor 3mg/500mg Tablet SR
Eriglim M 3mg/500mg Tablet SR
Dailyglim M 3mg/500mg Tablet SR
Frequently asked questions
What are the recommended storage conditions for Glimilife M 3mg/500mg Tablet SR?
Keep this medicine in the container or the pack it came in, tightly closed. Store it according to the instructions mentioned on the pack or label. Dispose of the unused medicine. Make sure it is not consumed by pets, children, and other people.
Can the use of Glimilife M 3mg/500mg Tablet SR lead to lactic acidosis?
Yes, the use of Glimilife M 3mg/500mg Tablet SR can lead to lactic acidosis. It is a medical emergency that causes increased levels of lactic acid in the blood. This can be known as MALA (Metformin-associated Lactic Acidosis). This is a rare side effect associated with metformin and therefore harmful for patients with underlying kidney disease, elderly patients or those who take large amounts of alcohol. If you experience symptoms like muscle pain or weakness, dizziness, tiredness, feeling cold in arms and legs, difficulty breathing, nausea, vomiting, stomach pain, or slow heart rate, stop taking Glimilife M 3mg/500mg Tablet SR and consult your doctor immediately.
What is Glimilife M 3mg/500mg Tablet SR?
Glimilife M 3mg/500mg Tablet SR is a combination of two medicines: Glimepiride and Metformin. This medicine is used in the treatment of type 2 diabetes mellitus (DM). It improves blood glucose levels in adults when taken along with proper diet and regular exercise. Glimepiride lowers blood glucose levels by increasing the release of insulin from the pancreas. Metformin works by lowering the glucose production in the liver and improving insulin sensitivity. This combination is not indicated for the treatment of type 1 DM.
What are the possible side effects of Glimilife M 3mg/500mg Tablet SR?
Common side effects include hypoglycemia (low blood sugar level), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects can include lactic acidosis. Long-term use can also lead to Vitamin B12 deficiency.
Can the use of Glimilife M 3mg/500mg Tablet SR lead to Vitamin B12 deficiency?
Yes, long-term use of Glimilife M 3mg/500mg Tablet SR can cause vitamin B12 deficiency. It interferes with the absorption of vitamin B12 in the stomach. If untreated, this may lead to anemia and nerve problems and symptoms include tingling sensation and numbness in hands and feet, weakness, urinary problems, change in mental status and difficulty in maintaining balance (ataxia). To prevent this issue, some researchers suggest a daily intake of vitamin B12 from outside sources at least once every year.
Can the use of Glimilife M 3mg/500mg Tablet SR lead to hypoglycemia?
Yes, the use of Glimilife M 3mg/500mg Tablet SR can cause hypoglycemia (low blood sugar level). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. It is more likely to occur if you miss your meals, drink alcohol, over-exercise, or take other antidiabetic medications along with it. Regular monitoring of blood sugar levels is important. Always keep a quick source of sugar like glucose tablets, honey, or fruit juice with you.
Is it safe to take alcohol while I am also taking Glimilife M 3mg/500mg Tablet SR?
No, it is not safe to take Glimilife M 3mg/500mg Tablet SR along with alcohol. It can lower blood sugar levels and increase the risk of lactic acidosis.
